Nerea Lazcanoiturburu, Juan García-Sáez, Carlos González-Corralejo, Cesáreo Roncero, Julián Sanz, Carlos Martín-Rodríguez, M Pilar Valdecantos, Adoración Martínez-Palacián, Laura Almalé, Paloma Bragado, Silvia Calero-Pérez, Almudena Fernández, María García-Bravo, Carmen Guerra, Lluis Montoliu, José Carlos Segovia, Ángela M Valverde, Isabel Fabregat, Blanca Herrera, Aránzazu Sánchez
Despite the well-known hepatoprotective role of the epidermal growth factor receptor (EGFR) pathway upon acute damage, its specific actions during chronic liver disease, particularly cholestatic injury, remain ambiguous and unresolved. Here, we analyzed the consequences of inactivating EGFR signaling in the liver on the regenerative response following cholestatic injury. For that, transgenic mice overexpressing a dominant negative mutant human EGFR lacking tyrosine kinase activity (ΔEGFR) in albumin-positive cells were submitted to liver damage induced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC), an experimental model resembling human primary sclerosing cholangitis...
August 17, 2022: Journal of Pathology